Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
M Ventures
AddedFeb 17, 2024
UpdatedJun 28, 2026
M Ventures

M Ventures

Operating

Merck Ventures BV: A global venture capital firm specializing in healthcare, life science, and startups.

Location
Amsterdam, North Holland, NL
Founded
2014
Firm
Compare
Portfolio
Employees

Merck Ventures BV operates as a venture capital firm.

The Firm focuses on healthcare, life science, performance materials, and start up businesses. Merck Ventures serves customers worldwide.

M Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments35
Current Portfolio Count27
Total Portfolio Exits0

Top Investment Stages

Series A17 (50.0%)
Series B9 (26.5%)
Seed6 (17.6%)
Pre-Seed1 (2.9%)
Series C1 (2.9%)

Stage Mix

Series A 50%Series B 26%Seed 18%Pre-Seed 3%Series C 3%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Polaris Electro-Optics logo

Polaris Electro-Optics

CellFE logo

CellFE

Celestial AI logo

Celestial AI

ImmuneBridge logo

ImmuneBridge

Sonde Health logo

Sonde Health

Oxford Sciences Innovation logo

Oxford Sciences Innovation

Metalenz logo

Metalenz

Pictor Labs logo

Pictor Labs

Concerto Biosciences logo

Concerto Biosciences

Plexium logo

Plexium

Biolinq logo

Biolinq

Immunitas Therapeutics logo

Immunitas Therapeutics

Soteria Biotherapeutics logo

Soteria Biotherapeutics

Medisafe logo

Medisafe

Tipe logo

Tipe

Neurable logo

Neurable

Simulate logo

Simulate

Ribometrix logo

Ribometrix

Safari AI logo

Safari AI

ApoGen Biotechnologies logo

ApoGen Biotechnologies

Vantage Point logo

Vantage Point

Gamelynx logo

Gamelynx

FanAI logo

FanAI

Indi Molecular logo

Indi Molecular

Progyny logo

Progyny

M Ventures - Similar Investment Firms

Merck Capital Ventures logo

Merck Capital Ventures

merck.com

Merrick Ventures logo

Merrick Ventures

Meritus Ventures logo

Meritus Ventures

Merlin Ventures logo

Merlin Ventures

merlin.vc

Merck Global Health Innovation Fund logo

Merck Global Health Innovation Fund

Inbio Ventures logo

Inbio Ventures

Global Life Science Ventures logo

Global Life Science Ventures

Merus Capital logo

Merus Capital

meruscap.com

MDC Ventures logo

MDC Ventures

Monarch Ventures logo

Monarch Ventures

McKesson Ventures logo

McKesson Ventures

Maverick Ventures logo

Maverick Ventures

3M New Ventures logo

3M New Ventures

3m.com

DSM Venturing logo

DSM Venturing

venturing.dsm.com

Mercuri logo

Mercuri

mercuri.vc

M Ventures - Classification

Also Known As
  • Merck Ventures B.V.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end